Fitness7 months ago
SGLT2 Inhibitors Add to GLP-1s’ Cardio, Kidney Benefits
STOCKHOLM — In the treatment of type 2 diabetes, sodium-glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide 1 receptor agonists (GLP-1 RAs) show independent benefits that...
